Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols

<i>Bovine alphaherpesvirus 1</i> is ubiquitous in cattle populations and is associated with several clinical syndromes, including respiratory disease, genital disease, infertility and abortions. Control of the virus in many parts of the world is achieved primarily through vaccination wit...

Full description

Bibliographic Details
Main Authors: Laureana De Brun, Mauro Leites, Agustín Furtado, Fabricio Campos, Paulo Roehe, Rodrigo Puentes
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/4/408
_version_ 1797536986803732480
author Laureana De Brun
Mauro Leites
Agustín Furtado
Fabricio Campos
Paulo Roehe
Rodrigo Puentes
author_facet Laureana De Brun
Mauro Leites
Agustín Furtado
Fabricio Campos
Paulo Roehe
Rodrigo Puentes
author_sort Laureana De Brun
collection DOAJ
description <i>Bovine alphaherpesvirus 1</i> is ubiquitous in cattle populations and is associated with several clinical syndromes, including respiratory disease, genital disease, infertility and abortions. Control of the virus in many parts of the world is achieved primarily through vaccination with either inactivated or live modified viral vaccines. The objective of this study was to evaluate the performance of four commercially available BoHV-1 vaccines commonly used in Central and South America. Animals were divided into eight groups and vaccinated on days 0 and 30. Groups 1 to 4 received two doses of four different BoHV-1 commercial vaccines (named A to D). Groups 5 and 6 received vaccine D plus a vaccine for either Clostridial or Food-and-Mouth-Disease (FMD), respectively. Group 7 received one dose of two different brands of reproductive vaccines. Serum samples were collected from all animals on days 0, 30 and 60 to evaluate neutralizing and isotype-specific (IgG1 and IgG2) antibodies. Of the four commercial vaccines evaluated, only vaccine A induced neutralizing antibodies to titers ≥ 1:8 in 13/15 (86%) of the animals 60 days post-vaccination. Levels of IgG2 antibody increased in all groups, except for group 2 after the first dose of vaccine B. These results show that only vaccine A induced significant and detectable levels of BoHV-1-neutralizing antibodies. The combination of vaccine D with Clostridial or FMD vaccines did not affect neutralizing antibody responses to BoHV-1. The antibody responses of three of the four commercial vaccines analyzed here were lower than admissible by vaccine A. These results may be from vaccination failure, but means to identify the immune signatures predictive of clinical protection against BoHV-1 in cattle should also be considered.
first_indexed 2024-03-10T12:09:43Z
format Article
id doaj.art-7a648f5aaf5b4d2e9a5f37495ca1c4ab
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T12:09:43Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-7a648f5aaf5b4d2e9a5f37495ca1c4ab2023-11-21T16:21:07ZengMDPI AGVaccines2076-393X2021-04-019440810.3390/vaccines9040408Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization ProtocolsLaureana De Brun0Mauro Leites1Agustín Furtado2Fabricio Campos3Paulo Roehe4Rodrigo Puentes5Departamento de Patobiología, Facultad de Veterinaria, Universidad de la República, Montevideo 11600, UruguayDepartamento de Patobiología, Facultad de Veterinaria, Universidad de la República, Montevideo 11600, UruguayDepartamento de Patobiología, Facultad de Veterinaria, Universidad de la República, Montevideo 11600, UruguayLaboratório de Bioinformática & Biotecnologia, Campus de Gurupi, Universidade Federal do Tocantins, Gurupi 77410-530, BrazilInstituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rio Grande do Sul, Porto Alegre 90050-170, BrazilDepartamento de Patobiología, Facultad de Veterinaria, Universidad de la República, Montevideo 11600, Uruguay<i>Bovine alphaherpesvirus 1</i> is ubiquitous in cattle populations and is associated with several clinical syndromes, including respiratory disease, genital disease, infertility and abortions. Control of the virus in many parts of the world is achieved primarily through vaccination with either inactivated or live modified viral vaccines. The objective of this study was to evaluate the performance of four commercially available BoHV-1 vaccines commonly used in Central and South America. Animals were divided into eight groups and vaccinated on days 0 and 30. Groups 1 to 4 received two doses of four different BoHV-1 commercial vaccines (named A to D). Groups 5 and 6 received vaccine D plus a vaccine for either Clostridial or Food-and-Mouth-Disease (FMD), respectively. Group 7 received one dose of two different brands of reproductive vaccines. Serum samples were collected from all animals on days 0, 30 and 60 to evaluate neutralizing and isotype-specific (IgG1 and IgG2) antibodies. Of the four commercial vaccines evaluated, only vaccine A induced neutralizing antibodies to titers ≥ 1:8 in 13/15 (86%) of the animals 60 days post-vaccination. Levels of IgG2 antibody increased in all groups, except for group 2 after the first dose of vaccine B. These results show that only vaccine A induced significant and detectable levels of BoHV-1-neutralizing antibodies. The combination of vaccine D with Clostridial or FMD vaccines did not affect neutralizing antibody responses to BoHV-1. The antibody responses of three of the four commercial vaccines analyzed here were lower than admissible by vaccine A. These results may be from vaccination failure, but means to identify the immune signatures predictive of clinical protection against BoHV-1 in cattle should also be considered.https://www.mdpi.com/2076-393X/9/4/408BoHV-1BoHV-1 vaccines in a field herdClostridialFMD
spellingShingle Laureana De Brun
Mauro Leites
Agustín Furtado
Fabricio Campos
Paulo Roehe
Rodrigo Puentes
Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols
Vaccines
BoHV-1
BoHV-1 vaccines in a field herd
Clostridial
FMD
title Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols
title_full Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols
title_fullStr Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols
title_full_unstemmed Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols
title_short Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols
title_sort field evaluation of commercial vaccines against infectious bovine rhinotracheitis ibr virus using different immunization protocols
topic BoHV-1
BoHV-1 vaccines in a field herd
Clostridial
FMD
url https://www.mdpi.com/2076-393X/9/4/408
work_keys_str_mv AT laureanadebrun fieldevaluationofcommercialvaccinesagainstinfectiousbovinerhinotracheitisibrvirususingdifferentimmunizationprotocols
AT mauroleites fieldevaluationofcommercialvaccinesagainstinfectiousbovinerhinotracheitisibrvirususingdifferentimmunizationprotocols
AT agustinfurtado fieldevaluationofcommercialvaccinesagainstinfectiousbovinerhinotracheitisibrvirususingdifferentimmunizationprotocols
AT fabriciocampos fieldevaluationofcommercialvaccinesagainstinfectiousbovinerhinotracheitisibrvirususingdifferentimmunizationprotocols
AT pauloroehe fieldevaluationofcommercialvaccinesagainstinfectiousbovinerhinotracheitisibrvirususingdifferentimmunizationprotocols
AT rodrigopuentes fieldevaluationofcommercialvaccinesagainstinfectiousbovinerhinotracheitisibrvirususingdifferentimmunizationprotocols